STOCK TITAN

[Form 4] SI-BONE, Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Negative)
Form Type
4
Rhea-AI Filing Summary

Michael A. Pisetsky, SVP, Ops & Adm and Chief Legal Officer of SI-BONE, Inc. (SIBN), reported sales on 08/18/2025 that were executed to satisfy tax withholding obligations on vesting restricted stock units through a "sell-to-cover" process. The filing shows two non-derivative dispositions: 1,851 shares sold at a weighted-average price of $15.6524 and 1,478 shares sold at a weighted-average price of $15.6171, with transaction prices ranging from $15.49 to $15.80. After these transactions the reporting person beneficially owned 258,352 shares. The filing discloses that 138,504 of those shares are issuable upon settlement of restricted stock units, each representing a contingent right to one share.

Michael A. Pisetsky, SVP, Ops & Adm e Chief Legal Officer di SI-BONE, Inc. (SIBN), ha comunicato vendite effettuate il 08/18/2025 per soddisfare obblighi fiscali legati alla ritenuta sulle restricted stock unit in scadenza, tramite un'operazione di "sell-to-cover". La segnalazione indica due cessioni non derivati: 1.851 azioni vendute a prezzo medio ponderato di $15.6524 e 1.478 azioni vendute a prezzo medio ponderato di $15.6171, con prezzi di transazione compresi tra $15.49 e $15.80. Dopo queste operazioni la persona segnalante possedeva beneficiariamente 258.352 azioni. La comunicazione specifica che 138.504 di queste azioni sono emettibili alla liquidazione delle restricted stock unit, ciascuna rappresentante il diritto condizionato a una azione.

Michael A. Pisetsky, SVP de Operaciones y Administración y Chief Legal Officer de SI-BONE, Inc. (SIBN), informó ventas el 08/18/2025 realizadas para cubrir obligaciones fiscales por la retención sobre unidades restringidas que vencían, mediante un proceso de "sell-to-cover". La presentación muestra dos disposiciones no derivadas: 1,851 acciones vendidas a un precio promedio ponderado de $15.6524 y 1,478 acciones vendidas a un precio promedio ponderado de $15.6171, con precios de transacción entre $15.49 y $15.80. Tras estas operaciones, la persona informante poseía beneficiariamente 258,352 acciones. El expediente revela que 138,504 de esas acciones son emitibles al liquidarse las unidades restringidas, cada una representando un derecho contingente a una acción.

Michael A. Pisetsky, SI-BONE, Inc.(SIBN) 운영·관리 담당 수석부사장 겸 법무책임자는 08/18/2025에 만기되는 제한부 주식 단위(RSU)의 세금 원천징수 의무를 충족하기 위해 "sell-to-cover" 방식으로 매도했다고 보고했습니다. 보고서에는 두 건의 비파생 처분이 기재되어 있습니다: 가중평균가격 $15.6524에 매도된 1,851주, 가중평균가격 $15.6171에 매도된 1,478주이며, 거래 가격대는 $15.49에서 $15.80입니다. 해당 거래 후 보고인은 258,352주를 실질적으로 보유하고 있었습니다. 보고서에는 그 중 138,504주가 제한부 주식 단위의 정산 시 발행될 예정이며, 각 단위는 한 주에 대한 조건부 권리를 나타낸다고 명시되어 있습니다.

Michael A. Pisetsky, SVP Ops & Adm et Chief Legal Officer de SI-BONE, Inc. (SIBN), a déclaré des ventes le 08/18/2025 effectuées pour satisfaire des obligations fiscales liées à la retenue sur des restricted stock units arrivant à échéance, via un processus de "sell-to-cover". Le dépôt indique deux cessions non dérivées : 1 851 actions vendues à un prix moyen pondéré de $15.6524 et 1 478 actions vendues à un prix moyen pondéré de $15.6171, avec des prix de transaction allant de $15.49 à $15.80. Après ces opérations, la personne déclarante détenait bénéficiairement 258 352 actions. Le dossier précise que 138 504 de ces actions sont attribuables lors de la liquidation des restricted stock units, chacune représentant un droit conditionnel à une action.

Michael A. Pisetsky, SVP Ops & Adm und Chief Legal Officer von SI-BONE, Inc. (SIBN), meldete Verkäufe am 08/18/2025, die durchgeführt wurden, um Steuerabzugsverpflichtungen im Zusammenhang mit fällig gewordenen Restricted Stock Units durch ein "sell-to-cover"-Verfahren zu erfüllen. Die Meldung zeigt zwei nicht-derivative Veräußerungen: 1.851 Aktien verkauft zu einem gewichteten Durchschnittspreis von $15.6524 und 1.478 Aktien verkauft zu einem gewichteten Durchschnittspreis von $15.6171, mit Transaktionspreisen zwischen $15.49 und $15.80. Nach diesen Transaktionen besaß die meldende Person wirtschaftlich 258.352 Aktien. Die Meldung gibt an, dass 138.504 dieser Aktien bei der Abwicklung der Restricted Stock Units auszugegeben sind, wobei jede Einheit ein bedingtes Recht auf eine Aktie darstellt.

Positive
  • Sale designated as "sell-to-cover" indicating the transactions were for tax withholding on RSU vesting, not discretionary insider selling
  • Transparent price disclosure including weighted-average prices and provided range ($15.49–$15.80) with offer to supply per-trade details on request
  • Beneficial ownership reported clearly, including the number of shares issuable upon RSU settlement (138,504)
Negative
  • None.

Insights

TL;DR: Routine sell-to-cover tax withholding; limited market impact and no change to insider's overall stake beyond RSU settlement.

The reported transactions are non-discretionary sales to satisfy tax withholding tied to RSU vesting, not open-market liquidity trades. Total reported dispositions equal 3,329 shares executed across multiple trades at prices between $15.49 and $15.80. The insider's beneficial ownership after the trades is 258,352 shares, including 138,504 shares issuable on settlement of RSUs. These facts indicate the activity is administrative and not necessarily informative about management's view of company prospects. From a financial-materiality perspective, the volumes and dollar values are small relative to a typical public float and unlikely to affect valuation or market dynamics materially.

TL;DR: Compliance-driven insider sale consistent with standard post-vesting tax procedures; disclosure appears complete.

The Form 4 specifies the sales were executed to cover tax withholding obligations associated with RSU vesting and documents the price range and weighted-average prices. The filer offers to provide details of individual trade prices on request, which supports transparency. Beneficial ownership reporting includes both currently owned shares and those issuable upon RSU settlement, aligning with disclosure norms. No departures from expected governance or reporting practices are evident in the filing.

Michael A. Pisetsky, SVP, Ops & Adm e Chief Legal Officer di SI-BONE, Inc. (SIBN), ha comunicato vendite effettuate il 08/18/2025 per soddisfare obblighi fiscali legati alla ritenuta sulle restricted stock unit in scadenza, tramite un'operazione di "sell-to-cover". La segnalazione indica due cessioni non derivati: 1.851 azioni vendute a prezzo medio ponderato di $15.6524 e 1.478 azioni vendute a prezzo medio ponderato di $15.6171, con prezzi di transazione compresi tra $15.49 e $15.80. Dopo queste operazioni la persona segnalante possedeva beneficiariamente 258.352 azioni. La comunicazione specifica che 138.504 di queste azioni sono emettibili alla liquidazione delle restricted stock unit, ciascuna rappresentante il diritto condizionato a una azione.

Michael A. Pisetsky, SVP de Operaciones y Administración y Chief Legal Officer de SI-BONE, Inc. (SIBN), informó ventas el 08/18/2025 realizadas para cubrir obligaciones fiscales por la retención sobre unidades restringidas que vencían, mediante un proceso de "sell-to-cover". La presentación muestra dos disposiciones no derivadas: 1,851 acciones vendidas a un precio promedio ponderado de $15.6524 y 1,478 acciones vendidas a un precio promedio ponderado de $15.6171, con precios de transacción entre $15.49 y $15.80. Tras estas operaciones, la persona informante poseía beneficiariamente 258,352 acciones. El expediente revela que 138,504 de esas acciones son emitibles al liquidarse las unidades restringidas, cada una representando un derecho contingente a una acción.

Michael A. Pisetsky, SI-BONE, Inc.(SIBN) 운영·관리 담당 수석부사장 겸 법무책임자는 08/18/2025에 만기되는 제한부 주식 단위(RSU)의 세금 원천징수 의무를 충족하기 위해 "sell-to-cover" 방식으로 매도했다고 보고했습니다. 보고서에는 두 건의 비파생 처분이 기재되어 있습니다: 가중평균가격 $15.6524에 매도된 1,851주, 가중평균가격 $15.6171에 매도된 1,478주이며, 거래 가격대는 $15.49에서 $15.80입니다. 해당 거래 후 보고인은 258,352주를 실질적으로 보유하고 있었습니다. 보고서에는 그 중 138,504주가 제한부 주식 단위의 정산 시 발행될 예정이며, 각 단위는 한 주에 대한 조건부 권리를 나타낸다고 명시되어 있습니다.

Michael A. Pisetsky, SVP Ops & Adm et Chief Legal Officer de SI-BONE, Inc. (SIBN), a déclaré des ventes le 08/18/2025 effectuées pour satisfaire des obligations fiscales liées à la retenue sur des restricted stock units arrivant à échéance, via un processus de "sell-to-cover". Le dépôt indique deux cessions non dérivées : 1 851 actions vendues à un prix moyen pondéré de $15.6524 et 1 478 actions vendues à un prix moyen pondéré de $15.6171, avec des prix de transaction allant de $15.49 à $15.80. Après ces opérations, la personne déclarante détenait bénéficiairement 258 352 actions. Le dossier précise que 138 504 de ces actions sont attribuables lors de la liquidation des restricted stock units, chacune représentant un droit conditionnel à une action.

Michael A. Pisetsky, SVP Ops & Adm und Chief Legal Officer von SI-BONE, Inc. (SIBN), meldete Verkäufe am 08/18/2025, die durchgeführt wurden, um Steuerabzugsverpflichtungen im Zusammenhang mit fällig gewordenen Restricted Stock Units durch ein "sell-to-cover"-Verfahren zu erfüllen. Die Meldung zeigt zwei nicht-derivative Veräußerungen: 1.851 Aktien verkauft zu einem gewichteten Durchschnittspreis von $15.6524 und 1.478 Aktien verkauft zu einem gewichteten Durchschnittspreis von $15.6171, mit Transaktionspreisen zwischen $15.49 und $15.80. Nach diesen Transaktionen besaß die meldende Person wirtschaftlich 258.352 Aktien. Die Meldung gibt an, dass 138.504 dieser Aktien bei der Abwicklung der Restricted Stock Units auszugegeben sind, wobei jede Einheit ein bedingtes Recht auf eine Aktie darstellt.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
X
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
PISETSKY MICHAEL A.

(Last) (First) (Middle)
C/O SI-BONE, INC.
471 EL CAMINO REAL, SUITE 101

(Street)
SANTA CLARA CA 95050

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
SI-BONE, Inc. [ SIBN ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
SVP, Ops & Adm/Chief Legal Ofr
3. Date of Earliest Transaction (Month/Day/Year)
08/18/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 08/18/2025 S(1) 1,851 D $15.6524(2) 259,830 D
Common Stock 08/18/2025 S(1) 1,478 D $15.6171(2) 258,352(3) D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.
2. This transaction was executed in multiple trades at prices ranging from $15.49 USD to $15.80 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
3. Includes 138,504 shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
Remarks:
/s/ Michael A. Pisetsky 08/20/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did SI-BONE insider Michael Pisetsky sell on 08/18/2025 (SIBN)?

He sold a total of 3,329 shares in two non-derivative transactions (1,851 and 1,478 shares) to satisfy tax withholding on vested RSUs.

At what prices were the SIBN shares sold in this Form 4?

Trades were executed at prices ranging from $15.49 to $15.80; the reported weighted-average prices were $15.6524 and $15.6171.

How many SI-BONE shares does Michael Pisetsky beneficially own after the reported transactions?

The Form 4 reports beneficial ownership of 258,352 shares following the reported sales.

How many shares are issuable upon settlement of Michael Pisetsky's RSUs?

The filing states 138,504 shares are issuable on settlement of restricted stock units granted to the reporting person.

Were these sales discretionary trades or administrative transactions?

The filing states the sales were to satisfy tax withholding obligations related to RSU vesting and were a "sell-to-cover" transaction, not discretionary.
Si-Bone

NASDAQ:SIBN

SIBN Rankings

SIBN Latest News

SIBN Latest SEC Filings

SIBN Stock Data

670.41M
38.38M
2.98%
96.16%
4.33%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
SANTA CLARA